HCV New Drug Research - Stories Contributed
Protease inhibitors improved sustained virologic response rate in HCV
Healthcare | Dec 12 2012 19:5465
Monoclonal antibody GS-6624 well tolerated by patients with hepatic fibrosis in initial safety study
Healthcare | Dec 03 2012 16:3279
Boceprevir and Telaprevir-Direct Anti-HCV Drugs Show Good Response in Routine Practice
Healthcare | Dec 03 2012 16:3228
Hepatitis C-Lessons From The Liver Meeting
Healthcare | Nov 30 2012 15:4155
Sofosbuvir (GS-7977) Hepatitis C drug shows promise in late-stage trial
Healthcare | Nov 30 2012 01:20281
Hepatitis C Responds Better to Triple Antiviral Therapy
Healthcare | Nov 27 2012 10:2024
Which patients should be prioritised for new hepatitis C treatments?
Healthcare | Nov 26 2012 19:5221
Multiple study results indicate safety, efficacy of sofosbuvir (GS-7977) in HCV patients
Healthcare | Nov 22 2012 23:1392
AASLD - BIT225 Hepatitis C Virus 48-week data
Healthcare | Nov 18 2012 17:0133
Hepatitis C-Managing Adverse Effects and Complications in Completing Treatment
Healthcare | Nov 18 2012 17:0029
Hepatitis C in the DAA era during the current economic crisis: Whom to treat? How to treat? When to treat?
Healthcare | Nov 15 2012 20:5061
AASLD - FibroScan Most Reliable Test for Assessing Severe Fibrosis and Cirrhosis in Alcoholic Liver Disease
Healthcare | Nov 15 2012 20:4598
Hepatitis C Drug Derailed by Deal
Healthcare | Nov 15 2012 07:10780
Daclatasvir and Sofosbuvir: Promising HCV Combo May Not See Light of Day
Healthcare | Nov 15 2012 07:10641
AASLD- Interferon-Free Regimens Produce High HCV Sustained Response
Healthcare | Nov 14 2012 19:5362
AASLD - Drug Combos Hit Hep C Virus Hard
Healthcare | Nov 14 2012 01:3294
Abbott Announces Phase 3 Interferon-free Hepatitis C Regimens to be Studied in Broad Patient Populations
Healthcare | Nov 14 2012 01:3228
Gilead May Top Rivals With Hepatitis C Therapy Results
Healthcare | Nov 13 2012 14:4141
AASLD-R E P E A T -- Interim Phase II Data of Merck's Investigational MK-5172
Healthcare | Nov 13 2012 14:4157
AASLD-Daclatasvir, Asunaprevir and BMS-791325 Achieved SVR12 of 94% in Treatment-Naïve Patients with Geno 1 Chronic Hepatitis C
Healthcare | Nov 13 2012 14:4137
AASLD-HALT-HE Study Underscores Role of Ammonia in Hepatic Encephalopathy
Healthcare | Nov 12 2012 23:00183
AASLD 2012: Danoprevir and Mericitabine Work for Prior Non-responders, Hep C Patients with Cirrhosis
Healthcare | Nov 12 2012 23:0056
AASLD - Novartis' Certican succeeds in liver transplant trial
Healthcare | Nov 12 2012 23:0032
AASLD-Phase 2 Results Show Incivo (telaprevir), in Combination With Peginterferon Alfa/Ribavirin, Effective in Patients Co-infected With Genotype-1 Chronic Hepatitis C Virus and HIV
Healthcare | Nov 12 2012 23:0021
AASLD-Achillion Programs: Sovaprevir, ACH-3102 and ACH-2684
Healthcare | Nov 12 2012 23:0098
AASLD-Phase III Analyses on Anemia Management With Victrelis (Boceprevir) Combination Therapy, Including Cirrhotic Patients
Healthcare | Nov 12 2012 22:5550
AASLD-Daclatasvir and Asunaprevir Achieved SVR12 in 78% of Difficult-to-Treat Genotype 1b Prior Null Responders
Healthcare | Nov 11 2012 16:2559
AASLD- Data from Phase 2B Trials of Simeprevir (TMC435) in Hepatitis C Patients with Advanced Fibrosis
Healthcare | Nov 11 2012 16:25215
AASLD- ALS-2200 (VX-135), Vertex's Oral Nucleotide Analogue in Development for Hepatitis C
Healthcare | Nov 11 2012 03:40293
AASLD-100 Percent Sustained Virologic Response Rate (SVR4) Interferon-Free Regimen of Sofosbuvir (GS-7977), GS-5885 and Ribavirin in Treatment-Na ïve Geno 1 Hepatitis C Infected Patients
Healthcare | Nov 11 2012 03:40318
AASLD-Merck MK-5172 Hepatitis C Drug Shows Promise in Study; Abbott Updates Data
Healthcare | Nov 11 2012 03:40327
AASLD- Idenix Reports On IDX719 and IDX184
Healthcare | Nov 11 2012 03:4036
AASLD- BI 201335 and BI 207127: Interferon-Free Hepatitis C Treatment Show Viral Cure Achieved in Up to 85% Of Treatment-Naive
Healthcare | Nov 10 2012 14:23246
Boehringer Ingelheim to start late-stage hepatitis C drug trial
Healthcare | Nov 10 2012 14:2342
AASLD- Abbott hepatitis C oral drugs bring high cure rates in trial
Healthcare | Nov 10 2012 14:22121
Hepatitis C Abstracts- Help Navigating The AASLD Website
Healthcare | Nov 10 2012 14:2230
Gilead, Abbott Unwrap Dueling Hep C Pill Data
Healthcare | Nov 10 2012 14:2236
Perspectives and challenges of interferon-free therapy for chronic hepatitis C
Healthcare | Nov 10 2012 14:2294
Adam Feuerstein On The AASLD Meeting-Abbott vs. Gilead
Healthcare | Nov 09 2012 22:11217
Triple Therapy for Hepatitis C: High Cure Rate, Greater Risks
Healthcare | Nov 09 2012 22:1152
Boehringer Ingelheim Launches Hepatitis C Website
Healthcare | Nov 09 2012 22:1046
Review article: herbal and dietary supplement hepatotoxicity
Healthcare | Nov 09 2012 06:10172
Efficacy and safety of ribavirin plus pegylated interferon alfa in geriatric patients with chronic hepatitis C
Healthcare | Nov 09 2012 06:1027
TMC435 - Protease inhibitors as combination therapy in Hep C virus
Healthcare | Nov 06 2012 16:3358
Our Stem Cell Future: What's Next? - Larry Goldstein UCSD
Healthcare | Nov 05 2012 11:5134
Quality indicator adherence did not impact readmission, mortality in liver disease
Healthcare | Nov 05 2012 11:5134
New agents for the treatment of hepatitis C – focus on telaprevir
Healthcare | Nov 04 2012 06:3145
Hepatitis C virus infection and autoimmune diseases
Healthcare | Nov 03 2012 18:5253
Hepatitis C MK-5172:Merck Will Initiate all-oral, interferon-free combination
Healthcare | Nov 03 2012 06:2437
Hepatitis C-Why IL28B Genotype Remains Important With DAA Regimens
Healthcare | Nov 03 2012 06:2422
Hepatitis C-Avoiding Missteps When Evaluating New HCV Trial Data
Healthcare | Nov 03 2012 06:2426
FDA Hepatitis Update - Victrelis (boceprevir) labeling update
Healthcare | Nov 02 2012 20:2322
India revokes patent on Roche's Pegasys
Healthcare | Nov 02 2012 20:2360
Hepatitis C Interferon-free: Late-breaking Abstracts Selected for Oral Presentation at The Liver Meeting®
Healthcare | Nov 02 2012 20:2326
Mice with 'humanized' livers improve early drug testing, Stanford scientists show
Healthcare | Oct 31 2012 19:3221
AASLD President's Press Conference for The Liver Meeting®, Saturday, November 10, 2012
Healthcare | Oct 31 2012 19:3288
Hepatitis c clinical trials for October 2012-ClinicalTrials.gov
Healthcare | Oct 31 2012 19:3135
Incivek (Telaprevir)-Hepatitis C Geno 2 Patient Treated
Healthcare | Oct 30 2012 17:2231
Alisporivir (DEB025) - Cyclophilin Inhibitors: An Emerging Class of Therapeutics for the Treatment of Chronic Hepatitis C Infection
Healthcare | Oct 30 2012 01:31183
Rates of Transmitted HIV Drug Resistance Rising in the U.S.
Healthcare | Oct 29 2012 15:2121
Health Canada pulls distribution of Novartis flu vaccines
Healthcare | Oct 29 2012 15:2138
Federal Judge Grants permanent injunction against Oregon herb and supplement manufacturer
Healthcare | Oct 28 2012 01:2427
Telaprevir, boceprevir offer similar efficacy for most patients with HCV 1
Healthcare | Oct 27 2012 12:11477
Few HCV/HBV infections identified in adults with access to care
Healthcare | Oct 27 2012 12:1191
Hepatitis—Do you “C” it?
Healthcare | Oct 26 2012 22:5327
AASLD 2012-Galectin Therapeutics to Present New Data on the Treatment of Fatty Liver Disease and Fibrosis
Healthcare | Oct 26 2012 22:5325
MicroRNAs, Hepatitis C Virus, and HCV/HIV-1 Co-Infection: New Insights in Pathogenesis and Therapy
Healthcare | Oct 26 2012 22:5321
Diabetes in the Elderly Addressed in Consensus Report
Healthcare | Oct 26 2012 22:5322
Telaprevir therapy required tacrolimus dose reduction in liver transplant recipients with HCV
Healthcare | Oct 26 2012 22:5327
Hepatitis C - Finally a conference examines issue of drug diversion
Healthcare | Oct 26 2012 22:5326
Hepatitis C–What Are Your Treatment Choices: New Webinar
Healthcare | Oct 25 2012 01:4135
Gilead Raises Sales Guidance, Talks Up Strong HIV Drug Launch
Healthcare | Oct 23 2012 20:2129
TMC435 (Simeprevir)-Promising New Oral Therapy for Hepatitis C
Healthcare | Oct 23 2012 20:21233
Bristol-Myers brought Insight Public Affairs- Prepares to launch first hepatitis C drugs in UK.
Healthcare | Oct 23 2012 20:2044
Setbacks in HCV Drug Development Highlight Uncertainties in Treat or Wait Decisions
Healthcare | Oct 23 2012 04:1125
HCV Admissions Rise While HIV Ones Fall
Healthcare | Oct 23 2012 04:1160
Hepatitis C-Expected Launch of GS-7977 in 2015 will Pave the Way for an Oral Interferon-free Combination Therapy
Healthcare | Oct 23 2012 04:11175
Egypt launches world’s largest Hepatitis C patient registry
Healthcare | Oct 22 2012 14:5221
VX-135 (ALS-2200) Vertex Draws Collaboration Interest For Hepatitis C Combo
Healthcare | Oct 19 2012 17:0252
Players In Hepatitis C Treatment Market Officially In Play
Healthcare | Oct 19 2012 17:0223
Debilitating muscle cramps common among patients with cirrhosis
Healthcare | Oct 19 2012 04:3330
Simeprevir (TMC435) Data In Hepatitis C To Be Presented At The AASLD
Healthcare | Oct 19 2012 04:3389
Hepatitis C-BioCryst Pharmaceuticals and Presidio Pharmaceuticals to Merge
Healthcare | Oct 18 2012 15:3042
UPDATE: Abbott Hepatitis C Regimen Suppresses Virus in New Study
Healthcare | Oct 18 2012 15:3064
Interferon-free ABT-450 - Enanta enters phase 3 clinical trial for Hepatitis C
Healthcare | Oct 17 2012 23:22146
A New And Interesting Addition To The Hep C Clinical Pipeline
Healthcare | Oct 17 2012 23:2223
Are You Ready for Flu Season?
Healthcare | Oct 15 2012 01:1326
Triple Therapy for Chronic HCV Infection Is Cost-Effective in Some Patients
Healthcare | Oct 15 2012 01:1330
Severity of depression in hepatitis B and hepatitis C patients.
Healthcare | Oct 15 2012 01:1372
High Incidence of Parkinsonism in Patients With Liver Cirrhosis: Presented at ANA
Healthcare | Oct 15 2012 01:1338
Hepatitis C and Human Immunodeficiency Virus Type 1 (HIV) Research Study (Gilead GS334-0123)
Healthcare | Oct 15 2012 01:1336
Triple therapy with first generation HCV protease inhibitors: lead-in or no lead-in phase ?
Healthcare | Oct 14 2012 18:51107
Hepatitis C-Update on Diagnosis and Treatment
Healthcare | Oct 14 2012 18:5128
Part 2- 8 Renowned Hepatology Experts Answer 32 Questions On Hepatitis C
Healthcare | Oct 14 2012 18:5121
Hepatitis C Peg/Riba Therapy: With versus Without Fluvastatin-An Open-Label Randomized Controlled Study
Family | Aug 23 2012 16:5023
Medivir Hepatitis C Drug-TMC435(simeprevir) important component in future interferon-free treatments
Family | Aug 23 2012 16:50312
NH Hepatitis C Outbreak Grows To 27
Health | Jul 02 2012 22:1347
Supreme Court Upholds Entire Affordable Care Act
Health | Jun 28 2012 14:55519
Hepatitis B-Court Ruled Against Tennessee Veteran Who Claims He Contracted HBV At Murfreesboro VA Hospital
Health | Jun 02 2012 03:0050
U.S. Prepares Groundwork For Biosimilar Approval
Health | Jun 02 2012 02:4034
Load More ...

SignUp

Login